Detalhe da pesquisa
1.
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.
Rheumatology (Oxford)
; 61(11): 4263-4272, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179569